Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 29, 1997

View Archived Issues

Company Profile: Sugen

SS Pharm. patents new antifungal agents

New antiallergic agents from Dainippon Ink & Chemicals

Otsuka's new antidiabetic agents

FDA clears new oral treatment for hair loss in men

TOBI approved by FDA for management of CF patients

FDA approval obtained for Prandin

Teveten cleared for U.S. marketing

SAR leading to new topoisomerase I inhibitor presented by Banyu

Suntory in-licenses new antidementia agent

VRCTC-310: MTD, preliminary efficacy and pharmacokinetic data in humans

DX-9065a exhibits antithrombotic efficacy and no effects on hemostasis in animal model

Phase IIb trial of TCR vaccine for rheumatoid arthritis begins

Alferon evaluated in patients coinfected with HIV and HCV

MedImmune and BioTransplant plan to test MEDI-507 for graft-vs.-host disease

Alexion files IND for C5 inhibitor treatment for rheumatoid arthritis

NDA filed for extended-release Ditropan formulation

Triangle Pharmaceuticals plans to reinitiate trials with DMP-450

Lidak submits NDA for Lidakol

Aronex/Ferrer seek approval of Nyotran in Spain